Literature DB >> 19087131

Aetiology of cirrhosis of the liver has an impact on survival predicted by the Model of End-stage Liver Disease score.

B Angermayr1, A Luca, F König, G Bertolini, M Ploner, B Gridelli, G Ulbrich, T Reiberger, J Bosch, M Peck-Radosavljevic.   

Abstract

BACKGROUND: Originally, aetiology of liver disease has been incorporated into the computation of the Model of End-stage Liver Disease (MELD) score. Clinical observations prompted us to hypothesize that patients with viral and alcoholic cirrhosis may differ in predicted survival rates. Until now, no large representative studies evaluated the impact of aetiology on long-term survival predicted by the Child-Pugh and MELD scores.
MATERIALS AND METHODS: Four hundred and ninety-three patients who underwent transjugular intrahepatic portosystemic shunt implantation in Vienna, Austria, and Palermo, Italy, were included in this retrospective study. The main analyses were a logistic regression model and a Cox proportional hazards regression model calculating the interaction of the aetiology with the scores.
RESULTS: Both groups had similar survival rates (median 1377 and 1721 days for viral and alcoholic cirrhosis, respectively; P = 0.58), but patients with viral cirrhosis had significantly lower MELD scores (P = 0.002). In the Cox analysis, aetiology had a significant impact on the prediction of overall survival by MELD score. For 3-month survival, MELD score was adequately predictive for both groups. For 1-year survival, aetiology had a significant impact on survival, indicating that patients with identical scores but different aetiologies differed in survival rates. When stratifying patients into high- and low-risk patients (MELD < 16 vs. MELD >or= 16), aetiology of cirrhosis had no impact on the predictive value for low-risk patients; high-risk-patients (MELD >or= 16) with viral cirrhosis had significantly lower survival rates than patients with alcoholic cirrhosis and identical scores. With regard to Child-Pugh Score, no significant differences between the two patient groups and in the prediction of 3-month and 1-year survival could be observed.
CONCLUSIONS: Our study suggests that aetiology of cirrhosis has an impact on 1-year survival predicted by the MELD score. This becomes more apparent in patients with advanced stage of liver disease (MELD >or= 16). Since MELD score is used for ranking patients for liver transplantation and waiting times are regularly longer than 3 months, our observations suggest that with increasing time on the waiting list and severity of disease, patients with viral cirrhosis may have a disadvantage in the current allocation policy.

Entities:  

Mesh:

Year:  2009        PMID: 19087131     DOI: 10.1111/j.1365-2362.2008.02063.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  7 in total

1.  Clinical outcomes of compensated and decompensated cirrhosis: A long term study.

Authors:  Dimitrios N Samonakis; Mairi Koulentaki; Constantina Coucoutsi; Aikaterini Augoustaki; Chryssavgi Baritaki; Emmanuel Digenakis; Nikolaos Papiamonis; Maria Fragaki; Erminia Matrella; Maria Tzardi; Elias A Kouroumalis
Journal:  World J Hepatol       Date:  2014-07-27

2.  Sarcopenia and mortality after liver transplantation.

Authors:  Michael J Englesbe; Shaun P Patel; Kevin He; Raymond J Lynch; Douglas E Schaubel; Calista Harbaugh; Sven A Holcombe; Stewart C Wang; Dorry L Segev; Christopher J Sonnenday
Journal:  J Am Coll Surg       Date:  2010-06-26       Impact factor: 6.113

Review 3.  Model for End-stage Liver Disease.

Authors:  Ashwani K Singal; Patrick S Kamath
Journal:  J Clin Exp Hepatol       Date:  2012-12-01

4.  Alkaline phosphatase: the next independent predictor of the poor 90-day outcome in alcoholic hepatitis.

Authors:  Beata Kasztelan-Szczerbinska; Maria Slomka; Krzysztof Celinski; Mariusz Szczerbinski
Journal:  Biomed Res Int       Date:  2013-09-17       Impact factor: 3.411

5.  Prognostic nomogram for acute-on-chronic hepatitis B liver failure.

Authors:  Su Lin; Juan Chen; Mingfang Wang; Lifen Han; Haoyang Zhang; Jing Dong; Dawu Zeng; Jiaji Jiang; Yueyong Zhu
Journal:  Oncotarget       Date:  2017-09-18

6.  The von Willebrand Factor Facilitates Model for End-Stage Liver Disease-Independent Risk Stratification on the Waiting List for Liver Transplantation.

Authors:  Georg P Györi; David Pereyra; Benedikt Rumpf; Hubert Hackl; Christoph Köditz; Gregor Ortmayr; Thomas Reiberger; Michael Trauner; Gabriela A Berlakovich; Patrick Starlinger
Journal:  Hepatology       Date:  2020-04-23       Impact factor: 17.425

7.  The Addition of C-Reactive Protein and von Willebrand Factor to Model for End-Stage Liver Disease-Sodium Improves Prediction of Waitlist Mortality.

Authors:  Patrick Starlinger; Joseph C Ahn; Aidan Mullan; Georg P Gyoeri; David Pereyra; Roberto Alva-Ruiz; Hubert Hackl; Thomas Reiberger; Michael Trauner; Jonas Santol; Benedikt Simbrunner; Mattias Mandorfer; Gabriela Berlakovich; Patrick S Kamath; Julie Heimbach
Journal:  Hepatology       Date:  2021-08-29       Impact factor: 17.425

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.